Insights On Drug Discovery

  1. Long-Acting GnRH Antagonist For Advanced Prostate Cancer 10/16/2026

    Achieve rapid testosterone suppression for 6+ months with a novel low-volume subcutaneous depot formulation, eliminating the initial surge and offering a new approach for advanced prostate cancer treatment.

  2. Characterization And Functionality Of SEVs From Different MSC Purification Methods 10/9/2026

    Comparing two purification approaches for mesenchymal stem cell-derived small extracellular vesicles shows where identity, purity, and in vitro bioactivity align and where they diverge.

  3. Overview Of Recombinant Protein Expression Systems 10/1/2026

    Compare leading protein expression platforms and see how complexity, scalability, cost, and quality shape the path to commercial production.

  4. From Sequence To Scale In Seven Months 9/26/2026

    Accelerate recombinant protein development from sequence to scale while maintaining stable expression, manufacturing efficiency, and critical quality attributes.

  5. Manufacturing Glycosylated Erythropoietin Without š›¼1,3-Fucosylation 9/26/2026

    See how expression hosts affect recombinant EPO glycosylation, bioactivity, and consistency, with reproducible N-glycan profiles and absence of α1,3-linked fucosylation.

  6. The Art Of Protein Expression: A Guide To Understanding Difficult-To-Express Proteins 9/26/2026

    Protein expression failures often result from misfolding, PTMs, assembly issues, insolubility, and toxicity. Understanding their interplay can improve yields.

  7. Three Success Factors To Accelerate Your Program To Clinical Trial 9/23/2026

    Accelerating clinical timelines starts with a strong foundation. Discover how smart development strategies can reduce risk, conserve resources, and support future scale-up.

  8. Unlocking Challenging Targets With Macrocycle DNA-Encoded Libraries 9/22/2026

    Discover how macrocycle DNA-encoded libraries can uncover new opportunities for challenging targets and help researchers translate promising screening hits into starting points for drug discovery.

  9. AI Enabled Pharmaceutical Cocrystal Screening 9/3/2026

    Cocrystal candidate screening is resource-intensive and prone to gaps. This paper examines how AI-based modeling, trained on more than 20,000 data points, can sharpen candidate prioritization without sacrificing scientific rigor.

  10. Improving Bioprocessing Outcomes With The CHOZNĀ® Elite Host Cell Line 8/7/2026

    Accelerate cell line development with a host engineered for high expression, streamlined clone selection, flexible gene integration, and scalable industrial performance.